Warren L. DeSouza
2017
In 2017, Warren L. DeSouza earned a total compensation of $390.6K as Former Chief Financial Officer at Aimmune Therapeutics, a 77% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $29,050 |
|---|---|
| Salary | $96,833 |
| Other | $264,720 |
| Total | $390,603 |
DeSouza received $264.7K in other compensation, accounting for 68% of the total pay in 2017.
DeSouza also received $29.1K in non-equity incentive plan and $96.8K in salary.
Rankings
In 2017, Warren L. DeSouza's compensation ranked 12,668th out of 14,666 executives tracked by ExecPay. In other words, DeSouza earned more than 13.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 12,668 out of 14,666 | 14th |
Division Manufacturing | 4,986 out of 5,772 | 14th |
Major group Chemicals And Allied Products | 1,828 out of 2,075 | 12th |
Industry group Drugs | 1,521 out of 1,731 | 12th |
Industry Pharmaceutical Preparations | 1,178 out of 1,333 | 12th |
Source: SEC filing on April 11, 2018.
DeSouza's colleagues
We found five more compensation records of executives who worked with Warren L. DeSouza at Aimmune Therapeutics in 2017.
2017
Stephen Dilly
Aimmune Therapeutics
Chief Executive Officer
2017
Eric Bjerkholt
Aimmune Therapeutics
Chief Financial Officer
2017
Daniel Adelman
Aimmune Therapeutics
Chief Medical Officer
2017
Douglas Sheehy
Aimmune Therapeutics
General Counsel
2017
Jeffrey Knapp
Aimmune Therapeutics